Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Tremfya Market Size Changed, over the years?
In the past few years, the market size of Tremfya has grown by XX (HCAGR). Projections indicate it will rise from $XX million in 2024 to $XX million in 2025, showcasing a compound annual growth rate (CAGR) of XX%. The expansion during the historic period is linked to an increase in psoriasis and psoriatic arthritis cases, intensified focus on targeted therapy, escalating healthcare investments, the rise of specialty clinics, and heightened use of biologics in dermatology and rheumatology sectors.
How Much Will the Tremfya Market Be Worth in 2029?
It is predicted that the tremfya market will experience an XX (FCAGR) growth in the coming years. By 2029, its value is estimated to reach $XX million, having grown at a compound annual growth rate (CAGR) of XX%. This forecasted expansion can be credited to developments in healthcare facilities, a rise in the adoption of point-of-care testing, increased healthcare research funding, and a greater emphasis on accurate treatment methods. Several trends are expected within the forecast period, like improvements in treatment methods, tailored approaches to medicine, technological advancements in patient monitoring, the inclusion of artificial intelligence (AI), and progress in injection device technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20343&type=smp
Which is the Largest Company in the Tremfya Market?
Major companies operating in the tremfya market are Johnson & Johnson
What Are the Main Market Drivers in the Tremfya Industry?
The escalation in autoimmune diseases is anticipated to fuel the expansion of the tremfya market in the future. These diseases occur when the body’s immune system erroneously assaults its cells, tissues, or organs, identifying them as foreign threats. The rise in autoimmune diseases stems from genetic predisposition, environmental factors, changes in lifestyle, heightened awareness, and enhanced diagnostic facilities. Tremfya, an antibody that targets interleukin-23 (IL-23), helps control autoimmune diseases by adjusting the immune system’s overactive reaction, reducing inflammation, and lessening symptoms in conditions like psoriasis and psoriatic arthritis. For example, in 2024, the Australian Institute of Health and Welfare, a government organization based in Australia, reported that there were 10,000 hospitalizations for rheumatoid arthritis in 2022, indicating a 25% rise from 8,000 the year before, with a hospitalization rate of 39 per 100,000 individuals. Consequently, the escalating prevalence of autoimmune diseases is propelling the growth of the tremfya market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=20343&type=smp
How Is the Tremfya Market Segments Structured?
The tremfya market covered in this report is segmented –
1) By Indication: Moderate-To-Severe Plaque Psoriasis; Active PsA
2) By Formulation: Subcutaneous Injection; Intravenous Infusion
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
4) By End User: Adult Patients; Geriatric Patients
What Strategic Trends Are Transforming the Tremfya Market?
One noticeable trend in the tremfya market is the pursuit and receipt of regulatory permissions to broaden its therapeutic applications, including for moderate-to-severe Crohn’s disease, which significantly expands its potential patient pool and market opportunities. Regulatory authorizations denote the formal permission accorded by regulatory bodies such as the Food and Drug Administration (FDA) or European Medicines Agency (EMA), which permit a drug to be sold for specific indications after proving its safety, effectiveness, and quality. For instance, in September 2024, Johnson & Johnson, an American multinational pharmaceutical firm, gained FDA clearance for TREMFYA (guselkumab) aimed at treating adults suffering from moderately to severely active ulcerative colitis, thereby making it the first interleukin-23 inhibitor with dual-action to be approved for treating this ailment. This approval was based on encouraging results from the Phase 2b/3 QUASAR trial, which demonstrated that roughly half of the subjects achieved clinical respite following a 44-week treatment period. TREMFYA works by aiming at interleukin-23, which aids in normalizing the inflammatory response within the colon.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/tremfya-global-market-report
Which Global Regions Offer the Highest Growth in the Tremfya Market?
North America was the largest region in the tremfy market in 2024. The regions covered in the tremfya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20343
This Report Delivers Insight On:
1. How big is the tremfya market, and how is it changing globally?
2. Who are the major companies in the tremfya market, and how are they performing?
3. What are the key opportunities and risks in the tremfya market right now?
4. Which products or customer segments are growing the most in the tremfya market?
5. What factors are helping or slowing down the growth of the tremfya market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model